primary myelofibrosis
Showing 26 - 50 of 99
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
-
Phoenix, Arizona
- +61 more
May 5, 2022
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],
Recruiting
- Myeloproliferative Neoplasm
- +5 more
- Apixaban 2.5 MG Oral Tablet [ELIQUIS]
- Aspirin 81 mg
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Apr 19, 2022
Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)
Recruiting
- Primary Myelofibrosis
- +9 more
- Observational
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Momelotinib
- +3 more
-
Phoenix, Arizona
- +166 more
Jan 27, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 7, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +4 more
- Eltrombopag Olamine
-
Houston, TexasM D Anderson Cancer Center
Jan 4, 2022
Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Terminated
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Best Available Therapy
-
Scottsdale, Arizona
- +121 more
Oct 21, 2021
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Duarte (procedure, drug, other)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 2, 2021
Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)
Active, not recruiting
- Primary Myelofibrosis
- +5 more
-
Aachen, Germany
- +16 more
Sep 28, 2021
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)
Completed
- Primary Myelofibrosis
- +2 more
-
Rochester, Minnesota(unnamed)
Aug 24, 2021
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
A Prospective, Two-arm, Non-interventional Study of JAKAVI® in
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Jakavi
-
Aachen, GermanyNovartis Investigative Site
Sep 6, 2021
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)
Terminated
- Primary Myelofibrosis
- +2 more
-
Scottsdale, Arizona
- +8 more
Jul 9, 2021
Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New
Completed
- Chronic Phase Myelofibrosis
- +3 more
-
Boston, Massachusetts
- +2 more
May 27, 2021
Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory
Active, not recruiting
- Acute Megakaryoblastic Leukemia
- +2 more
- Alisertib
- +2 more
-
Miami, Florida
- +2 more
May 4, 2021
Primary Myelofibrosis Trial (Pacritinib)
Withdrawn
- Primary Myelofibrosis
- Pacritinib
- (no location specified)
May 3, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary
Recruiting
- Myelofibrosis Transformation in Essential Thrombocythemia
- +2 more
- Elotuzumab
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2021